Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

1.5K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.5K
Methods of Documentation III: PIE01:21

Methods of Documentation III: PIE

2.1K
Problem-intervention-evaluation (PIE) is a systematic approach to documentation used in healthcare settings for clinical decision-making and patient care planning. It is a structured approach to organizing patient data based on problems, interventions, and evaluations. Here's a breakdown of its key features and considerations:
2.1K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

4.2K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.2K
Impression Management Techniques III: Aligning Actions01:29

Impression Management Techniques III: Aligning Actions

170
Aligning actions are communicative strategies individuals employ to maintain social harmony and preserve personal identity in the face of potential disruptions to social norms. These actions are particularly important in managing social impressions when one's behavior might be seen as inappropriate, incompetent, or morally questionable.Types of Aligning ActionsThe three principal types of aligning actions are disclaimers, accounts, and apologies.DisclaimersDisclaimers are preventive; they are...
170
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

1.5K
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
1.5K
Methods of Documentation IV: Focus Charting01:26

Methods of Documentation IV: Focus Charting

1.8K
Focus Charting, also known as the focus charting system or "focus documentation," is a systematic documentation approach used in healthcare to organize patient information in medical records.
It typically involves three columns for recording information:
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of hollow fiber systems to model treatment of infections: A practical guide.

iScience·2026
Same author

Quantitative Medicine to Support Drug Development and Regulatory Decisions: A UK Regulatory Approach Informed by ICH M15.

Clinical and translational science·2026
Same author

Pharmacokinetic-pharmacodynamic modeling using combined time-kill data for meropenem and colistin or polymyxin B combination effects in <i>Acinetobacter baumannii</i>.

Antimicrobial agents and chemotherapy·2026
Same author

Current practices in the use and monitoring of intravenous unfractionated heparin infusions - A cross-sectional UK survey.

Thrombosis research·2026
Same author

Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection.

npj antimicrobials and resistance·2026
Same author

Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report.

Pharmaceutics·2026
Same journal

Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same journal

A Narrative Review of Artificial Intelligence for Drug Repurposing: Lessons From COVID-19 and Oncology (2020-2025).

CPT: pharmacometrics & systems pharmacology·2026
Same journal

Butorphanol Pharmacokinetics Across Species: Meta-Analysis Integrating Allometric Scaling and Minimal Physiologically Based Pharmacokinetic Modeling.

CPT: pharmacometrics & systems pharmacology·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

Commentary on the MID3 Good Practices Paper.

Efthymios Manolis1,2, Jacob Brogren2,3, Susan Cole2,4

  • 1European Medicines Agency, London, UK.

CPT: Pharmacometrics & Systems Pharmacology
|June 28, 2017
PubMed
Summary
This summary is machine-generated.

The European Medicines Agency (EMA) established a working group to integrate modeling and simulation (M&S) in medicine development and regulatory review. This initiative aims to build expertise and harmonize M&S practices across the industry.

More Related Videos

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
05:00

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

2.0K
Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

5.0K

Related Experiment Videos

Last Updated: Feb 27, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
05:00

Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs

Published on: August 9, 2024

2.0K
Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

5.0K

Area of Science:

  • Pharmacometrics
  • Regulatory Science
  • Drug Development

Background:

  • The European Medicines Agency (EMA) has actively promoted the integration of modeling and simulation (M&S) in pharmaceutical development over the past decade.
  • Recognizing the need for regulatory expertise in M&S data, European regulators agreed to establish dedicated working groups.

Purpose of the Study:

  • To outline the establishment and objectives of the EMA Modelling and Simulation Working Group (MSWG).
  • To emphasize the importance of harmonizing good M&S practices and fostering dialogue between regulators and industry.
  • To acknowledge the contribution of industry initiatives, such as the EFPIA Model-Informed Drug Discovery and Development (MID3) group, in advancing M&S consistency.

Main Methods:

  • Workshops and collaborative discussions organized by the EMA.
  • Establishment of the EMA Modelling and Simulation Working Group (MSWG).
  • Recognition of industry-led initiatives promoting M&S best practices.

Main Results:

  • Agreement among European regulators on the necessity of building M&S expertise.
  • Formation of the EMA Modelling and Simulation Working Group (MSWG).
  • Consensus on the need for harmonized M&S practices and ongoing stakeholder dialogue.

Conclusions:

  • The EMA's efforts have led to the creation of a dedicated working group to enhance M&S integration in regulatory processes.
  • Harmonization of M&S practices and continuous collaboration are crucial for effective medicine development and assessment.
  • Industry initiatives play a vital role in promoting consistency and advancing the application of M&S.